Renal medullary carcinoma
Renal medullary carcinoma (pronunciation: /ˈriːnəl mɛdʊˈlɛəri kɑːrsɪˈnoʊmə/) is a rare type of cancer that originates in the kidney. It is most commonly associated with individuals who have sickle cell trait or disease.
Etymology
The term "renal" is derived from the Latin word renes, meaning kidneys. "Medullary" comes from the Latin medulla, which refers to the innermost part of a structure, in this case, the kidney. "Carcinoma" is a term used to describe a cancer that begins in the skin or in tissues that line or cover internal organs.
Symptoms
Symptoms of renal medullary carcinoma may include hematuria (blood in the urine), abdominal pain, weight loss, and a palpable abdominal mass.
Diagnosis
Diagnosis of renal medullary carcinoma typically involves imaging tests such as computed tomography (CT) scans or magnetic resonance imaging (MRI), and a biopsy of the kidney tissue.
Treatment
Treatment options for renal medullary carcinoma may include surgery, chemotherapy, radiation therapy, and targeted therapy. The choice of treatment depends on the stage of the cancer, the patient's overall health, and other factors.
Prognosis
The prognosis for renal medullary carcinoma is generally poor, with a median survival time of less than one year. However, early detection and treatment can improve survival rates.
See also
External links
- Medical encyclopedia article on Renal medullary carcinoma
- Wikipedia's article - Renal medullary carcinoma
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski